QA: Affymax INC in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001158223_2014_Affymax_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001158223, Affymax INC

  xvar xval
0 AssetsCurrent 6,322,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 1,121,000
4 LiabilitiesCurrent 8,871,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 27,529,000
9 ResearchAndDevelopmentExpense 11,857,000
10 remainder_Expenses -23,564,000
11 remainder_Revenues 1,369,000
12 remainder_NetIncome 29,000
13 remainder_ComprehensiveNetIncome 2,000
  yvar yval
0 Assets 7,443,000
1 Liabilities 8,871,000
2 Expenses 15,822,000
3 Revenues 1,369,000
4 StockholdersEquity -1,428,000
5 NetIncome -14,424,000
6 ComprehensiveNetIncome -14,423,000
7 BaseVar 16,768,000
8 EconomicCapitalRatiobeforeLimitedLiability -2.15
9 EconomicCapitalRatio 0.975

Edgar->Model Mapping

Feature Distribution

Change over Time